A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort.
- DOI
- 10.3390/biom13101481
- Published
- 2023 Oct 3
- Container
- Biomolecules
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/biom13101481,
title = {A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort.},
author = {Toro L and Rojas V and Conejeros C and Ayala P and Parra-Lucares A and Ahumada F and Almeida P and Silva MF and Bravo K and Pumarino C and Tong AM and Pinto ME and Romero C and Michea L},
year = {2023},
journal = {Biomolecules},
doi = {10.3390/biom13101481},
url = {https://doi.org/10.3390/biom13101481}
}RIS
TY - JOUR TI - A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort. AU - Toro L AU - Rojas V AU - Conejeros C AU - Ayala P AU - Parra-Lucares A AU - Ahumada F AU - Almeida P AU - Silva MF AU - Bravo K AU - Pumarino C AU - Tong AM AU - Pinto ME AU - Romero C AU - Michea L PY - 2023 JO - Biomolecules DO - 10.3390/biom13101481 UR - https://doi.org/10.3390/biom13101481 ER -
APA
L, T., V, R., C, C., P, A., A, P., F, A., P, A., MF, S., K, B., C, P., AM, T., ME, P., C, R., & L, M. (2023). A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort.. Biomolecules. https://doi.org/10.3390/biom13101481
Source records
- pubmed · retrieved 2026-09-26T02:54:00.063Z
- europe-pmc · retrieved 2026-09-26T02:54:00.054Z
- doaj · retrieved 2026-09-26T02:54:00.042Z